Alan Fuhrman
2006 - OncoGenex Pharmaceuticals
In 2006, Alan Fuhrman earned a total compensation of $486.8K as Former Senior Vice President and Chief Financial Officer at OncoGenex Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $94,900 |
|---|---|
| Option Awards | $137,780 |
| Salary | $245,699 |
| Other | $8,439 |
| Total | $486,818 |
Fuhrman received $245.7K in salary, accounting for 50% of the total pay in 2006.
Fuhrman also received $94.9K in non-equity incentive plan, $137.8K in option awards and $8.4K in other compensation.
Rankings
In 2006, Alan Fuhrman's compensation ranked 4,745th out of 7,022 executives tracked by ExecPay. In other words, Fuhrman earned more than 32.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,745 out of 7,022 | 32nd |
Division Manufacturing | 1,602 out of 2,413 | 34th |
Major group Chemicals And Allied Products | 421 out of 673 | 37th |
Industry group Drugs | 302 out of 518 | 42nd |
Industry In Vitro and In Vivo Diagnostic Substances | 14 out of 36 | 61st |
Source: SEC filing on April 13, 2009.
Fuhrman's colleagues
We found two more compensation records of executives who worked with Alan Fuhrman at OncoGenex Pharmaceuticals in 2006.